Peptide Synthesis Service for Cancer Vaccine

Online Inquiry

The development of personalized neoantigen peptide vaccines will specifically and effectively target cancer cells in individuals, opening a new door for cancer immunotherapy. Creative Biolabs has cGMP-certified production facilities and expertise that enable us to produce non-GMP and GMP grade peptides. Using state-of-the-art equipment and an experienced team with the latest technology, Creative Biolabs' comprehensive range of high-quality peptide synthesis services includes customized peptide synthesis, high-throughput peptide libraries, and peptide array services.

GMP Grade Peptide Synthesis

Creative Biolabs' GMP manufacturing facilities are designed in strict accordance with the FDA's GMP manufacturing guidelines. We produce peptides up to 50 amino acids in length ranging from grams to kilograms. Our manufacturing capabilities are designed to meet the needs of our customers:

Synthesis strategy (solid phase peptide synthesis, solution phase peptide synthesis)
Purification strategy (preparative HPLC, routine chromatography, ion exchange, gel chromatography, countercurrent distribution)
Flexibility and upscaling
Special customer requirements (dedicated production line)
Special equipment (enzyme device, electrolysis device)

Peptide Synthesis Services

Synthesis of micro to high-throughput peptide arrays and peptide libraries
Special peptide modification
Ultra long peptide
Polyepitope peptide
Comprehensive analysis including LC-MS / MS, MALDI-MS, HPLC, AAA, NMR, peptide sequencing
Peptide content determination to confirm identity and ensure quality

Peptide Applications

Small Molecular Drug Discovery

Antibody Generation

Vaccine Development

Peptide Synthesis-Related Service Portfolio

Vaccine target recognition
Epitope and new epitope discovery/validation
Immunogenicity and multi-antigen peptide synthesis
Immune monitoring
DNA and RNA sequencing of peripheral blood mononuclear cells from cancer patients
Prediction of personalized peptides with high affinity binding to HLA molecules
Using synthetic personalized peptides libraries to create personalized vaccines

For more details, please feel free to contact us for project quotations and more detailed information.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Key Updates

NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER

NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION

Novel Solution. (Creative Biolabs Authorized)

NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY

New Technology. (Creative Biolabs Authorized)

NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION